Please fill out the form below to get started and we’ll be in touch within 24 hours with next steps.
Call Us for Immediate Assistance (347) 691-3494
Imatinib mesylate is a drug used to treat the following cancers: acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases.
The brand name is commonly Gleevec™.
The common doses of Imatinib Mesylate are 100 mg or 400 mg tablets.
Some possible side effects of imatinib mesylate include low blood counts, nausea and vomiting, edema, muscle cramps and bone pain, diarrhea, hemorrhage, skin rash, fever, and other common side effects.
We believe that high deductibles and copays shouldn’t prevent anyone from receiving the medications they need. That’s why at QuickRx, we offer a Copay Assistance Program. This is designed to help patients reduce their copays and out-of-pocket costs for their medication. Our program partners with various foundations and manufacturer assistance programs to help make a patient’s medication affordable.
Here are the ways to apply for the program:
Imatinib Mesylate is a signal transduction inhibitor targeted therapy that’s particularly a protein-tyrosine kinase inhibitor. It’s used to attack the cancer cells without damaging normal cells in order to minimize side effects.
Imatinib Mesylate is a targeted therapy that comes in pill form.
Imatinib Mesylate is a pill taken orally either once or twice daily. Consult with your doctor about dose and schedule.
It’s critical to take this medication at around the same time everyday. If you miss a dose, don’t take the missed dose or double the next one. Check with your healthcare provider and resume your regular dosing schedule.